Literatur:
Originalarbeit: Remdesivir for the Treatment of Covid-19 — Final Report, NEJM 08.10.2020
Positionspapier: Therapie mit Dexamethason bei Patienten mit COVID-19, DGP 01.07.2020
Originalarbeit: Postexposure Hydroxychloroquine Does Not Prevent COVID-19, NEJM 03.06.2020
Originalarbeit: Remdesivir for the Treatment of Covid-19 — Preliminary Report, NEJM 22.05.2020
Originalarbeit: Compassionate Use of Remdesivir for Patients with Severe Covid-19, NEJM 10.04.2020
Editorial: Convalescent Plasma to Treat COVID-19 Possibilities and Challenges, JAMA 27.03.2020
Fachinformationen: